MSCCOP

		home :: clinical trials :: treatment trials :: clinical trials

		CLINICAL TRIALS

AVAILABLE CLINICAL TRIALS

Melanoma Clinical Trials
	Ref #	Title
Unresectable Locally Advance or Stage IV	ECOG E2607	DASATINIB IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR STAGE IV MUCOSAL, ACRAL AND VULVOVAGINAL MELANOMAS
Stage IIIc and IV	VIRALYTICS VLA-007	A PHASE 2 STUDY OF THE EFFICACY AND SAFETY OF INTRATUMORAL CAVATAK(COXSACKIEVIRUS A21, CVA21) IN PATIENTS WITH STAGE IIIC AND STAGE IV MALIGNANT MELANOMA
Adjuvant Resected High Risk	ECOG E1609	A PHASE III RANDOMIZED STUDY OF ADJUVANT IPILIMUMAB ANTI-CTLA4 THERAPY VERSUS HIGH-DOSE INTERFERON ALPHA-2B FOR RESECTED HIGH-RISK MELANOMA
Metastatic	CTEP NCI 8443	RANDOMIZED PHASE II TRIAL OF TEMOZOLOMIDE VERSUS HYD-SULFATE AZD6244 IN PATIENTS WITH METASTATIC UVEAL MELANOMA
Metastatic	DUS11T	NILOTINIB IN TKI RESISTANT OR INTOLERANT PATIENTS WITH METASTATIC MUCOSAL, ACRAL, OR CHRONICALLY SUN DAMAGED MELANOMA